Is AIO belly board device advantageous in all rectal cancer patients by Hempel, Dominika et al.
342
Original article
NOWOTWORY Journal of Oncology 
2017, volume 67, number 6, 342–348
DOI: 10.5603/NJO.2017.0056
© Polskie Towarzystwo Onkologiczne
ISSN 0029–540X
www.nowotwory.edu.pl
1Department of Oncology, Medical University of Białystok, Poland
2Department of Radiotherapy, Comprehensive Cancer Center in Białystok, Poland
3Radiation Oncology Division, Medical University of Białystok, Poland
4Department of Clinical Oncology, Comprehensive Cancer Center in Białystok, Poland
Is AIO belly board device advantageous in all rectal cancer patients 
irradiated in the pelvic area? 
Dominika Hempel1, 2, Joanna Mandrosz3, Marek Z. Wojtukiewicz1, 4,  
Tomasz Filipowski2, Ewa Sierko1, 2
Purpose. To compare the prone position on a flat table vs an “All in one” belly board device (AIO BBD) in rectal cancer 
patients (RCPs).
Material and methods. Fifteen RCPs scheduled for irradiation were scanned in the two evaluated positions. After 
tomography, they completed a questionnaire concerning positioning. The dose-volume histograms (DVHs) for the 
small bowel and bladder were compared for both immobilization methods and setup accuracy was analyzed in 
electronic portal imaging devices (EPIDs) and X-ray volume imaging (XVI) procedures.
Results. AIO BBD was accepted by the majority of RCPs and provided better DVHs for the small bowel than the prone 
position on a flat table. The setup reproducibility was within tolerance limit for patients with BMI ≤ 29 kg/m2. Patients 
with obesity regarded AIO BBD as uncomfortable and they presented mean setup shifts out of the tolerance limit in 
the Y axis — 5.9 mm. 
Conclusions. The AIO BBD should be recommended for RCPs, especially for those with BMI ≤ 29 kg/m2. 
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Introduction 
Radiotherapy is an integral part of the radical treatment 
of locally advanced rectal cancer patients (RCPs) [1]. Unfor-
tunately, pelvic area irradiation may be complicated by 
acute and/or late gastrointestinal as well as urinary toxicity, 
which is observed in 2–30% of RCPs [2–4]. In light of the 
information that there is an association between irradiated 
volume of the small bowel and intestinal complications 
[4–6], many concepts for decreasing bowel exposure to 
irradiation have been investigated. The amount of small 
bowel irradiated can be reduced by the use of what is known 
as a “full bladder protocol” [7, 8], the choice of a prone vs 
supine position of the patient [6, 9, 10] and the positioning 
of patients on a belly board device (BBD) [6, 11–18]. BBD 
implementation leads to an improvement of dose-volume 
histogram (DVH) in the small bowel in both pre- [7, 8] and 
postoperatively [3, 12] irradiated patients undergoing 3D 
conformal radiotherapy (3D-CRT) or intensity modulated 
radiotherapy (IMRT) [9, 11, 12, 19, 20]. Although both the 
entire bowel area and individual intestinal loops have been 
delineated by radiation oncologists, the majority of authors 
agree that single intestinal loop exposure is more predictive 
for acute and late toxicity than the entire bowel region [5, 
14, 21, 22]. Of note, the volume of small bowel receiving 15 
Gy (V15) and 45 Gy (V45) are the most relevant parameters 
for predicting toxicity using the normal tissue complication 
probability (NTCP) model [5, 21–23]. The volume of single 
loops receiving more than 15 Gy or 45 Gy should be kept 
under 120–150 cc and 78 cc, respectively [5, 21, 22]. Unfortu-
nately there are many types of BBDs commercially available 
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on the market, which impedes comparison of results from 
different studies. Namely, there are square belly boards with 
an adjustable size of the octagonal opening and position of 
its lower border [3, 24], devices with bladder compression 
[17] or boards with additional hole for testes [18] and, used 
in our study, an egg-shaped/one-size AIO (“All In One”) belly 
board device. 
The aim of the study was to compare subjective (rectal 
cancer patients preferences) and objective (DVHs and EPID/
XVI verification) aspects of AIO-based immobilization vs the 
prone position on a flat table.
Material and methods
Fifteen consecutive locally advanced RCPs (mean age 
and body weight were 65 years and 78 kg, respectively) 
scheduled to receive pre- (short scheme) or postoperative 
(long scheme) 3D-CRT in the pelvic area were evaluated 
prospectively. Approval for this study was obtained from the 
Human Care Committee of the Medical University in Bialy-
stok, Poland. Written informed consent was obtained from 
the patients. The demographic characteristics of the study 
group and radiotherapy details are presented in Table I.
Radiotherapy planning and treatment
A “full bladder” protocol was used in studied patients. 
They were asked to drink half a litre of water 40 minutes 
before simulation and delivery of radiotherapy. Each patient 
was immobilized twice during primary simulation 1. prone 
on a flat table with a kneefix under the shins (Fig. 1) and 2. on 
an AIO belly board device composed of individually selected 
styrofoam pieces with a special egg-shaped/one-size hole 
(Fig. 2a) and additional accessories like a kneefix and head 
bolster (Fig. 2b). Computed tomography (CT) scans were 
performed in each position. After CTs, patients were asked 
to fill out by themselves an institution developed question-
naire concerning their opinion about the positionings. The 
questionnaire contained 8 closed questions and 2 open qu-
estions assessing different characteristics of immobilization.
Respiratory motion of the patient’s body was deter-
mined during the simulation by measurement of shifts in 
the lateral positioning module in the isocentrum on the 
Z axis on the patient’s skin. Computed tomography scans 
were taken from the L3–L4 junction to the perineum with 
5 mm slice spacing. The clinical target volumes (CTVs) were 
defined according to RTOG recommendations on CT scans 
performed in two positions (with and without AIO BBD) 
[25] taking care that the size of the treatment fields were 
similar. The longitudinal extension of the planning target 
volume (PTV) (8–10 mm margin encompassing the CTV) 
were added for both CTs series. The delineation comprised 
the following OARs: the bladder, small intestine and heads 
of femoral bones. Taking into consideration the fact that the 
volume of the small bowel has two definitions in the lite-
rature, both the bowel area referred to as abdominal space 
(peritoneal cavity) excluding the colon and large vessels as 
well as single bowel loops were delineated 2 cm above the 
PTV (up to the L4–L5 interspace). The analyzed doses in the 
small bowel and bladder (Table II) were compared for two 
immobilization methods (the notation V5, V15, V25, etc. was 
Table I. Characteristics of the studied group — rectal cancer patients 
treated with pre- or postoperative 3D conformal radiation therapy 
(RT), n = 15
Characteristics Value
Age [yr]:
mean 
min–max
65
54–77
Sex:
F
M
BMI [kg/m2]:
< 25
25–29
> 29
TNM:
T3N0M0
T3N1M0
T3N2M0
T4N0M0
RT schedule:
25 Gy/5 Gy/5 fractions
50 Gy/2 Gy/25 fractions
RT:
Preoperative
Postoperative 
Megavoltage X photon beam energy:
6
15 
4
11
5
7
3
10
2
2
1
11
4
11
4
3
12
BMI — body mass index, F — female, M — man, T — tumor, N — nodes, M — 
metastases, Gy — grey
Figure 1. Patient in prone position on simulation coach with kneefix 
under the shins
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used for the volume that receives a maximum dose of 5, 15 
or 25 Gy, etc., respectively). All radiation treatment plans met 
ICRU-62 requirements. Treatment plans assumed to be the 
most clinically acceptable were carried out (14 plans were 
accepted for patients immobilized on AIO BBD, 1 plan — for 
patient immobilized in a prone position on flat table). 
Setup verification 
EPID (00 and 900 projections) as well as kV XVI (Elekta, 
v. 4.2) scans were performed for setup verification (14 pa-
tients were finally irradiated on AIO BBD and 1 patient was 
immobilized in a prone position on a flat table). In accor-
dance with the protocol, IGRT procedures were performed 
before the 1st, 2nd, 3rd and every 7th fractions as well as 
in the case of more than 5mm displacement in the pelvic 
area (long RT-schedule patients) or daily (short RT-schedule 
patients). The patient’s setup shifts on the X (lateral), Y (lon-
gitudinal), and Z (vertical) axes were evaluated. 
The data was analyzed statistically using Microsoft Excel 
and Statistica v.10 programs. The Spearman’s test ranks were 
chosen for verification of the hypotheses. A confidence level 
of 0.05 was accepted. 
Results
Patients’ opinions
The majority of respondents (approx. 70–80% depen-
ding on the question) regarded the AIO BBD as a convenient, 
stable, safe and/or simple to reproduce positioning method. 
A similar percentage of the respondents assessed the prone 
on a flat table position as safe (75%) but less than half felt 
stability (30%) or comfort (40%) when lying directly on the 
simulation couch. Finally, 73% of the respondents would 
choose the AIO positioning system if they were to decide 
and only one-fourth the position directly on the table. The 
patients who indicated the position on a flat table as better 
explained their choice with the fact that their body was less 
strained compared with AIO-based immobilization and they 
felt that their head and hands were in a more comfortable 
position. For patients who had chosen the AIO system, this 
immobilization was more stable and comfortable and did 
not cause any pain or pressure in the ribs or chest which they 
suffered in the position directly on the simulation couch. 
Of particular importance in terms of radiotherapy plan-
ning is the fact that 60% of respondents did not regard any 
of the positioning methods as unacceptable. However, 13% 
(n = 2) and 25% (n = 4) of the patients considered the AIO 
system or the flat on the table position as inappropriate, 
respectively. The mean weight of the patients who criticized 
one of the positioning methods differs significantly — pa-
tients who disapproved of the AIO BBD weighed a mean 83 
kg, while patients dissatisfied with the position directly on 
a flat table — a mean 63 kg.
Respiratory motion
The respiratory motion measured in the isocentrum 
determined during simulation was smaller on the AIO BBD 
(mean min–max, 2–5 mm), compared with the prone posi-
tion on a flat table (mean min–max, 5–15 mm)
Small bowel dose-volume distribution
Mean small bowel volume was significantly greater (p 
= 0.03) in patients positioned on the AIO BBD than directly 
on a flat table, calculating for all patients (2520 vs 2218 cc 
for bowel area and 820 vs 651 cc for single loops). 
The DVH for the small bowel in preoperative patients 
setting (n = 11) was more favorable on the AIO BBD vs on 
the flat table position. Small bowel volumes: SB-V5, -V15 and 
-V25 were smaller by 8, 5 and 4%, respectively on the AIO 
BBD compared with the prone on a flat table position for 
Figure 2. “All in One” belly board device (AIO BBD). AIO in position on 
simulation coach (A), head bolster (B)
Table II. Analyzed parameters of dose-volume distribution in the 
small intestine and bladder
Small intestine 
(bowel area and single loops)
Bladder
Short radiotherapy (total dose of 25 Gy)
V5, V15, V25 V15, V25
Long radiotherapy (total dose of 50 Gy)
V5, V15, V25, V30, V45, V50 V30, V50
* V5 — the volume of the organ which received the maximum dose of 5 Gy
A
B
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the bowel area (Fig. 3A) and by 11, 10 and 4%, respectively 
for single loops (Fig. 3C). 
The DVH for the small bowel was also better on the 
AIO BBD than the prone on a flat table position in patients 
irradiated postoperatively with a dose of 50 Gy: SB-V5, -V15, 
-V25, -V30 and V45 was reduced by 6, 10, 8, 8 and 5% for 
the bowel area and by 6, 12, 18, 11 and 4% for single loops, 
respectively (Fig. 3 B, D). 
The largest absolute reduction of the irradiated volume 
of the small bowel was predominantly seen in the low and 
intermediate dose areas of the treatment volume — V5-
V15 for short radiotherapy and V15-V30 for a long scheme 
(p < 0.05). The volume reduction does not correlate with 
gender, age, weight and sequence of radiation treatment 
vs surgery. There was no significant difference in V25 for 
short and V45-50 for long radiotherapy between the two 
analyzed positions (p > 0.05).
The unfavourable DVH for small bowel was observed 
on the AIO BBD in a patient with BMI calculated as more 
than 29 kg/m2 (Fig. 4). This patient assessed the AIO BBD as 
uncomfortable and claimed to have difficulty to fit their belly 
tissues into the opening. Taking into consideration patient’s 
opinion and the DVH, this individual patient was irradiated 
in the prone on a flat table position without the BBD. 
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Figure 3. Mean dose-volume histogram for the small bowel (A, B. Bowel area, C, D. Single loops) in preoperatively (total dose 25Gy, n = 11) and 
postoperatively (total dose 50Gy, n = 4) irradiated rectal cancer patients immobilized in two treatment positions (prone on a flat table and on an AIO BBD)
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Figure 4. Dose-volume histogram for the small bowel (A. Bowel area, 
B. Single loops) in preoperatively (total dose 25Gy) irradiated rectal 
cancer patients with BMI > 29 kg/m2 immobilized in two treatment 
positions (prone on flat table and on an AIO BBD)
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Bladder dose-volume distribution
The volume of the bladder on the AIO-based and prone 
on a flat table positions was similar (234 vs 241 cc, respecti-
vely, p > 0.05). The DVH for the bladder was not significantly 
different between two positioning methods (p > 0.05) in 
preoperative and postoperative patient settings in all ana-
lyzed parameters (Fig. 5 A, B).
EPID and kV XVI set-up discrepancies
Immobilization on the AIO BBD provided excellent re-
producibility of patient positioning. The setup errors detect-
ed in EPID and kV XVI scans did not exceed the tolerance 
limit approved for the pelvic area (≤ 5 mm). EPID analysis 
showed the greatest mean setup shifts on the X axis (2.7 mm, 
SD = 1.5). Lower mean setup errors were reported in the Y 
(2.3 mm, SD = 1.66) and Z (1.1 mm, SD = 0.84) directions. 
Setup displacement assessed in XVI scans were 3.7 mm, 
SD = 3.0; 2.6 mm, SD = 2.2 and 2.6 mm, SD = 2.3 on the Y, X 
and Z axes, respectively.
The detailed analysis showed that in patients with BMI 
≤ 29 kg/m2 the XVI verifications were within limits on all 
three axes. However, in obese patients (BMI > 29 kg/m2), 
the setup displacement exceeded 5mm on the Y axis (mean 
value 0.59 mm, min–max 0.1–13 mm) (Fig. 6). 
Discussion
To the best of our knowledge, this is the first study which 
comprehensively compares patient preferences, dose distri-
bution in organs at risk, and setup errors of the AIO BBD vs 
the prone position on a flat table in rectal cancer patients. 
The majority of patients assessed the AIO BBD as safe and 
comfortable and would choose it as a method of immobili-
zation. The reduced respiratory motion of the abdomen was 
an additional advantage of the AIO BBD. Our findings have 
also shown that the AIO BBD provides low and intermediate 
dose volume advantages in the small bowel (for the bowel 
area and single loops) compared with the prone position 
on a flat table, both in patients irradiated pre- as well as 
postoperatively. The lack of effect for high dose regions 
was probably due to the overlap between PTV and the 
bowel area or single loops. Additionally, analysis of setup 
shifts indicated that reproducibility is excellent and within 
tolerance limits for patients stabilized on the AIO BBD. These 
results are consistent with those reported in the literature 
regarding various commercially available BBDs [3, 6–8, 13, 
14, 16–18, 24] and confirm the conclusion that AIO BBD 
should be recommended as a method of immobilization in 
the majority of RCPs. However, some observations associat-
ed with patient weight are concerning and call for caution 
before recommending this device for all patients. It seems 
that patients with BMI > 29 kg/m2 may have difficulties 
with adapting to the one-size/egg-shaped opening found 
a relatively short distance from the head bolster. Although 
there was no significant correlation between dose-volume 
reduction in the small bowel and patient weight on the AIO 
BBD, the DVH for the small bowel for obese patients in this 
immobilization was worse compared with prone on a flat 
table. The V15 in the bowel area and single loops was as high 
as 237.8 and 41 cc on the AIO BBD and only 45.57 and 26.04 
cc in the prone on a flat table position, respectively. More-
over, the setup shifts in two other patients with BMI > 29 
kg/m2 irradiated, despite their negative opinion, on an AIO 
BBD due to the small advantage in DVHs for the small bowel, 
exceeded the tolerance limit on the Y axis. The maximum 
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Figure 5. Mean dose-volume histogram for the bladder in 
preoperatively (A), total dose 25 Gy, n = 11 and postoperatively (B), 
total dose 50 Gy, n = 4 irradiated rectal cancer patients immobilized 
in two treatment positions (prone on flat table and on an AIO BBD) 
Figure 6. Mean setup shifts in X, Y, Z axes according to body mass 
index (BMI) in rectal cancer patients irradiated on an AIO BBD (n = 14)
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value of setup displacement reached 13 mm. The observed 
setup errors indicate the need to adjust the immobilization 
method to patient weight. The clinical importance of patient 
immobilization in regard to gastrointestinal and urinary 
toxicity will be detected by the prospective phase II clinical 
trial (NCT01142713) titled “The Impact of Patient Positioning 
and Use of Belly Board on Small Bowel and Urinary Bladder 
Volume Irradiated in Patients Receiving Radiotherapy for 
Rectal Cancer” (www.clinicaltrials.gov).
It is difficult to relate our observations to other studies 
because there are no investigations dedicated to patients’ 
opinions about AIO BBD nor dose-volume distribution in the 
small bowel, and positioning verification for this particular 
immobilization has been so far only explored. Only Nijkamp 
[14] mentions, also in the discussion, that for some volun-
teers the small compression verge of BBD may be considered 
uncomfortable. Rajeev et al. [15] reports in their discussion, 
not in the results section, that body weight was found to be 
a factor that shows a trend toward more daily patient set up 
variations in the prone on a belly board vs the supine posi-
tion. The variations in the X, Y and Z directions were greater 
in two patients with bodyweight > 100 kg. The correlation 
between BMI of the patients and setup discrepancies were 
described in the literature for gynaecological or abdominal 
malignancies settings [26–28]. Additionally, Czuchraniuk 
et al. [29] reported an influence of muscle strain on setup 
errors in patients irradiated in the pelvic area, which may 
be the key problem for obese patients immobilized on an 
egg-shaped/one-size AIO BBD (they reported a forced, stra-
ined position of the body on this device). It seems that belly 
board-based positioning in rectal cancer patients requires 
an IGRT procedure every day to prevent missing the planned 
planning target volume [30]. 
What is interesting in the current analysis, the volumes 
of the bowel area and single loops were greater in AIO BBD 
compared with the prone on a flat table position. This find-
ing is in conflict with studies assessing other types of BBDs 
[3, 15]. The possible explanation is that BBDs are expected 
to reduce the volume of the small bowel within the pelvis 
[3]. In our study, the small bowel volume was delineated 2 
cm above PTV (at least L4–L5 junction) to present low dose 
regions on DVHs. Some part of abdominal cavity (which is 
greater in AIO BBD due to the opening in styrofoam than 
in position on flat table), outside of the PTV, was included. 
The other authors have used the lower upper edge of the 
delineation, as local recurrences occurred mainly in the 
lower pelvis, below the S1–S2 interspace [14, 15, 22, 31, 32]. 
However, our findings definitely showed that dose distribu-
tion in the absolute volume of the small bowel was advan-
tageous for AIO BBD. The newest international guidelines 
on delineation in rectal cancer [33] indicate that in the case 
of cT3, cN0 tumors without invasion of the mesorectal facia, 
the upper border of the radiotherapy field can be lowered to 
the cranial border of the mesorectum, corresponding with 
the bifurcation of the superior rectal artery, which reduces 
the volume of the small bowel within irradiated fields. 
Conclusions
Despite numerous limitations of the study (small num-
ber of patients with obesity, no clinical data about toxicity, 
single-institution investigation), it provides a good estimate 
of the value of AIO BBD in patients with BMI ≤ 29 kg/m2. The 
present findings showed that for these patients, AIO BBD 
provides better dose-volume distribution in the small bowel 
combined with excellent reproducibility compared with the 
prone on a flat table position. Additionally, patients assessed 
the AIO BBD as convenient and stable. However, patients 
with BMI > 29 kg/m2 should be positioned with greater 
care. Immobilization on AIO BBD may be uncomfortable 
for these patients, cause worse dose-volume distribution in 
the small bowel and/or result in unacceptable setup shifts. 
Larger studies are required to improve the statistical power 
of the analyzed variations.
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